STIMATE (NEEDS NO REFRIGERATION) Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Stimate (needs No Refrigeration), and what generic alternatives are available?
Stimate (needs No Refrigeration) is a drug marketed by Ferring Pharms Inc and is included in one NDA.
The generic ingredient in STIMATE (NEEDS NO REFRIGERATION) is desmopressin acetate. There are twenty drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the desmopressin acetate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Stimate (needs No Refrigeration)
A generic version of STIMATE (NEEDS NO REFRIGERATION) was approved as desmopressin acetate by MEITHEAL on October 15th, 1997.
Summary for STIMATE (NEEDS NO REFRIGERATION)
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 18 |
Patent Applications: | 5 |
Formulation / Manufacturing: | see details |
DailyMed Link: | STIMATE (NEEDS NO REFRIGERATION) at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for STIMATE (NEEDS NO REFRIGERATION)
US Patents and Regulatory Information for STIMATE (NEEDS NO REFRIGERATION)
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ferring Pharms Inc | STIMATE (NEEDS NO REFRIGERATION) | desmopressin acetate | SPRAY, METERED;NASAL | 020355-002 | Oct 24, 2007 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |